My father was diagnosed with stage three colorectal cancer when I was nineteen. It was, as these things always are, a phone call that split my life into before and after. The months that followed were a blur of hospital visits, chemotherapy sessions, and the quiet, private terror of watching someone you love lose weight, lose hair, lose the ability to eat without pain. Halfway through his treatment, his oncologist mentioned an immunotherapy trial that was recruiting patients with his specific genetic markers. My father was accepted, and within four months of starting the trial, his tumours had shrunk by over sixty percent. Today, he is in remission. I owe his life to a clinical trial — to the researchers who designed it, the patients before him who took risks, and the rigorous, painstaking process of evidence generation that underpins modern medicine. But as my gratitude settled, a new set of questions began to surface. How are patients selected for trials? Who gets excluded, and why? What happens to the data collected from participants, and who truly benefits from the knowledge generated? I realised that I didn’t just want to be grateful for medical research; I wanted to understand how it worked — and how it could be made more equitable, more transparent, and more accessible to the people who need it most.
That experience carried me into a degree in biomedical science, where I found myself drawn not just to the science of medicine but to the systems and ethics that govern how that science is translated into practice. When the time came to choose a dissertation topic, I was overwhelmed by the sheer breadth of medical and clinical research. I could study the design of randomised controlled trials, the ethics of placebo use, the barriers to diverse recruitment in clinical studies, the role of patient-reported outcomes, or the challenges of conducting research in low-resource settings. I needed a specific, researchable question. I began by exploring what other students had already investigated, and I came across a curated collection of medical and clinical research topics for students (you can browse them here: https://premierdissertations.com/medical-clinical-research-topics-for-students/) that helped me see the landscape. Some projects examined the factors that influence patient willingness to participate in trials, others analysed the representation of ethnic minorities in cancer research, and a few explored the ethical tensions between individual patient care and the pursuit of generalisable knowledge. That breadth gave me the confidence to settle on a question that felt deeply personal: what are the barriers to clinical trial participation among ethnic minority patients in the UK, and how can research institutions build trust and improve recruitment in communities that have historically been underserved by medical research?
Once I had my direction, I threw myself into the work. I interviewed patients, oncologists, research nurses, and community leaders. I sat in on recruitment sessions at hospitals and listened to the questions that potential participants asked — questions about side effects, about whether they were “guinea pigs,” about whether the research would benefit people like them. The stories were powerful and often painful. One woman, a Somali grandmother, told me she had declined a trial because no one had explained it in her language, and she was afraid of signing something she didn’t understand. A community health worker described the legacy of medical exploitation that made some patients deeply suspicious of research, regardless of how well-intentioned the current team might be. My dissertation argued that recruitment is not simply a logistical challenge but a relational one — requiring cultural humility, sustained community engagement, and a willingness to address the historical injustices that continue to shape trust in medical institutions. I recommended practical changes: culturally competent recruitment materials, longer consultation times for patients considering trials, and the inclusion of community health workers on research teams.
Writing that dissertation felt like a way of honouring the trial that saved my father, while also asking the hard questions about who benefits from research and who is left behind. If you’re a student considering a medical or clinical research topic, I’d encourage you to start with a moment that touched you personally — a diagnosis, a treatment, a conversation with a patient or a doctor that made you wonder why things are done the way they are. The best research questions don’t emerge from textbooks; they emerge from the real, messy, human experience of illness and healing. Then explore what other students have already done, and let their work help you shape your own inquiry into something that could, in its own small way, make medical research a little fairer for everyone.